Neurotrophin-regulated signalling pathways
Neurotrophins are a family of closely related proteins that were identified initially as survival factors for sensory and sympathetic neurons, and have since been shown to control many aspects of survival, development and function of neurons in both the peripheral and the central nervous systems. Each of the four mammalian neurotrophins has been shown to activate one or more of the three members of the tropomyosin-related kinase (Trk) family of receptor tyrosine kinases (TrkA, TrkB and TrkC). In addition, each neurotrophin activates p75 neurotrophin receptor (p75NTR), a member of the tumour necrosis factor receptor superfamily. Through Trk receptors, neurotrophins activate Ras, phosphatidyl inositol-3 (PI3)-kinase, phospholipase C-γ1 and signalling pathways controlled through these proteins, such as the MAP kinases. Activation of p75NTR results in activation of the nuclear factor-κB (NF-κB) and Jun kinase as well as other signalling pathways. Limiting quantities of neurotrophins during development control the number of surviving neurons to ensure a match between neurons and the requirement for a suitable density of target innervation. The neurotrophins also regulate cell fate decisions, axon growth, dendrite growth and pruning and the expression of proteins, such as ion channels, transmitter biosynthetic enzymes and neuropeptide transmitters that are essential for normal neuronal function. Continued presence of the neurotrophins is required in the adult nervous system, where they control synaptic function and plasticity, and sustain neuronal survival, morphology and differentiation. They also have additional, subtler roles outside the nervous system. In recent years, three rare human genetic disorders, which result in deleterious effects on sensory perception, cognition and a variety of behaviours, have been shown to be attributable to mutations in brain-derived neurotrophic factor and two of the Trk receptors.
Top-30
Journals
|
5
10
15
20
25
30
35
40
45
|
|
|
International Journal of Molecular Sciences
45 publications, 2.53%
|
|
|
PLoS ONE
41 publications, 2.3%
|
|
|
Journal of Neuroscience
33 publications, 1.85%
|
|
|
Molecular Neurobiology
27 publications, 1.52%
|
|
|
Neuroscience
24 publications, 1.35%
|
|
|
Frontiers in Cellular Neuroscience
20 publications, 1.12%
|
|
|
Scientific Reports
20 publications, 1.12%
|
|
|
Journal of Biological Chemistry
20 publications, 1.12%
|
|
|
Neuroscience Letters
19 publications, 1.07%
|
|
|
Frontiers in Molecular Neuroscience
17 publications, 0.95%
|
|
|
Journal of Neurochemistry
17 publications, 0.95%
|
|
|
Proceedings of the National Academy of Sciences of the United States of America
17 publications, 0.95%
|
|
|
Frontiers in Neuroscience
16 publications, 0.9%
|
|
|
Neuropharmacology
16 publications, 0.9%
|
|
|
Journal of Neuroscience Research
16 publications, 0.9%
|
|
|
Brain Research
14 publications, 0.79%
|
|
|
European Journal of Neuroscience
14 publications, 0.79%
|
|
|
Behavioural Brain Research
12 publications, 0.67%
|
|
|
Molecular and Cellular Neurosciences
12 publications, 0.67%
|
|
|
Cells
11 publications, 0.62%
|
|
|
Journal of Molecular Neuroscience
10 publications, 0.56%
|
|
|
Cellular and Molecular Neurobiology
10 publications, 0.56%
|
|
|
Cell and Tissue Research
10 publications, 0.56%
|
|
|
Experimental Neurology
10 publications, 0.56%
|
|
|
Cell Death and Disease
9 publications, 0.51%
|
|
|
Vitamins and Hormones
9 publications, 0.51%
|
|
|
Neuroscience and Biobehavioral Reviews
8 publications, 0.45%
|
|
|
Progress in Neuro-Psychopharmacology and Biological Psychiatry
8 publications, 0.45%
|
|
|
Neuron
8 publications, 0.45%
|
|
|
5
10
15
20
25
30
35
40
45
|
Publishers
|
50
100
150
200
250
300
350
400
450
500
|
|
|
Elsevier
474 publications, 26.6%
|
|
|
Springer Nature
316 publications, 17.73%
|
|
|
Wiley
174 publications, 9.76%
|
|
|
MDPI
126 publications, 7.07%
|
|
|
Frontiers Media S.A.
100 publications, 5.61%
|
|
|
Taylor & Francis
52 publications, 2.92%
|
|
|
Public Library of Science (PLoS)
49 publications, 2.75%
|
|
|
Cold Spring Harbor Laboratory
37 publications, 2.08%
|
|
|
Society for Neuroscience
36 publications, 2.02%
|
|
|
SAGE
28 publications, 1.57%
|
|
|
Oxford University Press
25 publications, 1.4%
|
|
|
Hindawi Limited
25 publications, 1.4%
|
|
|
American Society for Biochemistry and Molecular Biology
21 publications, 1.18%
|
|
|
American Physiological Society
18 publications, 1.01%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
17 publications, 0.95%
|
|
|
American Chemical Society (ACS)
15 publications, 0.84%
|
|
|
Bentham Science Publishers Ltd.
14 publications, 0.79%
|
|
|
The Company of Biologists
14 publications, 0.79%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
14 publications, 0.79%
|
|
|
Pleiades Publishing
11 publications, 0.62%
|
|
|
Walter de Gruyter
9 publications, 0.51%
|
|
|
Impact Journals
7 publications, 0.39%
|
|
|
European Molecular Biology Organization
6 publications, 0.34%
|
|
|
Rockefeller University Press
6 publications, 0.34%
|
|
|
Cambridge University Press
6 publications, 0.34%
|
|
|
American Society for Cell Biology (ASCB)
6 publications, 0.34%
|
|
|
Federation of American Societies for Experimental Biology (FASEB)
5 publications, 0.28%
|
|
|
Royal Society of Chemistry (RSC)
5 publications, 0.28%
|
|
|
American Association for the Advancement of Science (AAAS)
5 publications, 0.28%
|
|
|
50
100
150
200
250
300
350
400
450
500
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.